Benzinga | Aug 9, 2021 04:41PM EDT

Fulgent Genetics Q2 EPS $2.55 Misses $2.81 Estimate, Sales $153.62M Miss $197.34M Estimate

Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $2.55 per share which missed the analyst consensus estimate of $2.81 by 9.25 percent. This is a 1400 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $153.62 million which missed the analyst consensus estimate of $197.34 million by 22.16 percent. This is a 789.75 percent increase over sales of $17.27 million the same period last year.